Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Nebraska
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Northwestern University
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Fred Hutchinson Cancer Center